Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Net Income (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Net Income for 8 consecutive years, with $12.9 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 154.47% to $12.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$49.3 million through Dec 2025, down 132.9% year-over-year, with the annual reading at $885000.0 for FY2025, N/A changed from the prior year.
  • Net Income for Q4 2025 was $12.9 million at Precision Biosciences, up from -$20.0 million in the prior quarter.
  • The five-year high for Net Income was $25.4 million in Q2 2024, with the low at -$30.7 million in Q4 2021.
  • Average Net Income over 5 years is -$10.1 million, with a median of -$11.3 million recorded in 2021.
  • Peak annual rise in Net Income hit 387.07% in 2024, while the deepest fall reached 731.66% in 2024.
  • Over 5 years, Net Income stood at -$30.7 million in 2021, then skyrocketed by 70.5% to -$9.1 million in 2022, then surged by 68.49% to -$2.9 million in 2023, then tumbled by 731.66% to -$23.7 million in 2024, then surged by 154.47% to $12.9 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at $12.9 million, -$20.0 million, and -$21.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.